| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 151, Issue 10 5408-5415, Copyright © 1993 by American Association of Immunologists
ARTICLES |
M Battegay, D Moskophidis, H Waldner, MA Brundler, WP Fung-Leung, TW Mak, H Hengartner and RM Zinkernagel
Department of Pathology, University of Zurich, Switzerland.
After infection with some viruses that tend to persist, neutralizing antibodies are generated rather late, i.e., after 1 to 3 mo. This has been observed for HIV, Hepatitis B infection in man, or after infection with lymphocytic choriomeningitis virus (LCMV) in mice. In contrast, nonneutralizing antibodies to LCMV are generated by day 7 and reach high titers by day 10. This study attempts to evaluate reasons for late and low titered neutralizing antibody responses. After a primary infection with low doses (10(2) plaque forming units) of the poorly cytopathic LCMV-WE, neutralizing antibodies were rarely produced at detectable levels before days 60 to 120. In vivo depletion of CD8+ CTL led to a marked enhancement and acceleration of kinetics of the neutralizing antibody response. In contrast, nonneutralizing antibodies, including those specific for LCMV-GP carrying the neutralizing determinant, were detectable very early, i.e., 4 to 7 days after infection, with maximum titers usually by day 10 irrespective of the presence or absence of CTL. Mice completely lacking CD8+ T cells because of deletion by homologous recombination (CD8-/-) also exhibited neutralizing antibodies early by day 10 to 20, and by day 120 reached very high titers. The neurotropic isolate LCMV-ARMSTRONG induced low but significant titers of neutralizing antibodies relatively early (i.e., by days 7 to 10), whereas the lympho-viscerotrope mutant virus LCMV-ARMSTRONG Cl-13 did not. Early and effective CTL responses causing immunopathology (and immunosuppression) correlated with the absence of neutralizing antibodies. The discrepancy between the CTL-dependent inhibition of neutralizing versus unimpaired anti-GP ELISA responses cannot be explained by different Ag doses alone. Additionally, it may reflect different kinetics of the responses, whereby the later neutralizing responses possibly requiring IgG affinity maturation may be more susceptible to general immunosuppression; also B cells expressing neutralizing receptors, but not those with antibodies binding GP (or NP), may be actively infected, therefore they present viral peptides on class I MHC Ag and may become targets for anti-LCMV- specific CTL.
This article has been cited by other articles:
|
|
 |
|
  M. S. Zinkernagel, B. Bolinger, P. Krebs, L. Onder, S. Miller, and B. Ludewig Immunopathological Basis of Lymphocytic Choriomeningitis Virus-Induced Chorioretinitis and Keratitis J. Virol., January 1, 2009; 83(1): 159 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Truong and D. B. McGavern A Novel Virus Carrier State to Evaluate Immunotherapeutic Regimens: Regulatory T Cells Modulate the Pathogenicity of Antiviral Memory Cells J. Immunol., July 15, 2008; 181(2): 1161 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Eschli, R. M. Zellweger, A. Wepf, K. S. Lang, K. Quirin, J. Weber, R. M. Zinkernagel, and H. Hengartner Early Antibodies Specific for the Neutralizing Epitope on the Receptor Binding Subunit of the Lymphocytic Choriomeningitis Virus Glycoprotein Fail To Neutralize the Virus J. Virol., November 1, 2007; 81(21): 11650 - 11657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Klenovsek, F. Weisel, A. Schneider, U. Appelt, S. Jonjic, M. Messerle, B. Bradel-Tretheway, T. H. Winkler, and M. Mach Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells Blood, November 1, 2007; 110(9): 3472 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Belnoue, P. Fontannaz-Bozzotti, S. Grillet, P.-H. Lambert, and C.-A. Siegrist Protracted Course of Lymphocytic Choriomeningitis Virus WE Infection in Early Life: Induction but Limited Expansion of CD8+ Effector T Cells and Absence of Memory CD8+ T Cells J. Virol., July 15, 2007; 81(14): 7338 - 7350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bergthaler, D. Merkler, E. Horvath, L. Bestmann, and D. D. Pinschewer Contributions of the lymphocytic choriomeningitis virus glycoprotein and polymerase to strain-specific differences in murine liver pathogenicity J. Gen. Virol., February 1, 2007; 88(2): 592 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Stiasny, S. Kiermayr, H. Holzmann, and F. X. Heinz Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites J. Virol., October 1, 2006; 80(19): 9557 - 9568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Matter, B. Odermatt, H. Yagita, J.-M. Nuoffer, and A. F. Ochsenbein Elimination of chronic viral infection by blocking CD27 signaling J. Exp. Med., September 4, 2006; 203(9): 2145 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hangartner, R. M. Zellweger, M. Giobbi, J. Weber, B. Eschli, K. D. McCoy, N. Harris, M. Recher, R. M. Zinkernagel, and H. Hengartner Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread J. Exp. Med., August 7, 2006; 203(8): 2033 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Kemball, E. D. H. Lee, E. Szomolanyi-Tsuda, T. C. Pearson, C. P. Larsen, and A. E. Lukacher Costimulation Requirements for Antiviral CD8+ T Cells Differ for Acute and Persistent Phases of Polyoma Virus Infection J. Immunol., February 1, 2006; 176(3): 1814 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Logvinoff, M. E. Major, D. Oldach, S. Heyward, A. Talal, P. Balfe, S. M. Feinstone, H. Alter, C. M. Rice, and J. A. McKeating Neutralizing antibody response during acute and chronic hepatitis C virus infection PNAS, July 6, 2004; 101(27): 10149 - 10154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Chen, A. E. Fraire, I. Joris, R. M. Welsh, and L. K. Selin Specific History of Heterologous Virus Infections Determines Anti-Viral Immunity and Immunopathology in the Lung Am. J. Pathol., October 1, 2003; 163(4): 1341 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Martinic, T. Rulicke, A. Althage, B. Odermatt, M. Hochli, A. Lamarre, T. Dumrese, D. E. Speiser, D. Kyburz, H. Hengartner, et al. Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC PNAS, February 18, 2003; 100(4): 1861 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rodriguez, S. Harkins, M. K. Slifka, and J. L. Whitton Immunodominance in Virus-Induced CD8+ T-Cell Responses Is Dramatically Modified by DNA Immunization and Is Regulated by Gamma Interferon J. Virol., March 27, 2002; 76(9): 4251 - 4259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ou, S. Zhou, L. Huang, and D. Moskophidis Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells J. Virol., September 15, 2001; 75(18): 8407 - 8423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Furrer, T. Bilzer, L. Stitz, and O. Planz Neutralizing Antibodies in Persistent Borna Disease Virus Infection: Prophylactic Effect of gp94-Specific Monoclonal Antibodies in Preventing Encephalitis J. Virol., January 15, 2001; 75(2): 943 - 951. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kopf, A. J. Coyle, N. Schmitz, M. Barner, A. Oxenius, A. Gallimore, J.-C. Gutierrez-Ramos, and M. F. Bachmann Inducible Costimulator Protein (ICOS) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection J. Exp. Med., July 3, 2000; 192(1): 53 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Seiler, B. M. Senn, P. Klenerman, U. Kalinke, H. Hengartner, and R. M. Zinkernagel Additive Effect of Neutralizing Antibody and Antiviral Drug Treatment in Preventing Virus Escape and Persistence J. Virol., July 1, 2000; 74(13): 5896 - 5901. [Abstract] [Full Text]
|
|
|
|
|
|
D. D. Pinschewer, A. F. Ochsenbein, B. Odermatt, V. Brinkmann, H. Hengartner, and R. M. Zinkernagel FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory J. Immunol., June 1, 2000; 164(11): 5761 - 5770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ciurea, P. Klenerman, L. Hunziker, E. Horvath, B. Odermatt, A. F. Ochsenbein, H. Hengartner, and R. M. Zinkernagel Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice PNAS, October 12, 1999; 96(21): 11964 - 11969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Hassett, J. Zhang, and J. L. Whitton Induction of Antiviral Antibodies by DNA Immunization Requires neither Perforin-Mediated nor CD8+-T-Cell-Mediated Lysis of Antigen-Expressing Cells J. Virol., September 1, 1999; 73(9): 7870 - 7873. [Abstract] [Full Text]
|
|
|
|
|
|
C. Lopez-Macias, U. Kalinke, M. Cascalho, M. Wabl, H. Hengartner, R. M. Zinkernagel, and A. Lamarre Secondary Rearrangements and Hypermutation Generate Sufficient B Cell Diversity to Mount Protective Antiviral Immunoglobulin Responses J. Exp. Med., June 7, 1999; 189(11): 1791 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oxenius, M. M. A. Martinic, H. Hengartner, and P. Klenerman CpG-Containing Oligonucleotides Are Efficient Adjuvants for Induction of Protective Antiviral Immune Responses with T-Cell Peptide Vaccines J. Virol., May 1, 1999; 73(5): 4120 - 4126. [Abstract] [Full Text]
|
|
|
|
|
|
P. Seiler, U. Kalinke, T. Rulicke, E. M. Bucher, C. Bose, R. M. Zinkernagel, and H. Hengartner Enhanced Virus Clearance by Early Inducible Lymphocytic Choriomeningitis Virus-Neutralizing Antibodies in Immunoglobulin-Transgenic Mice J. Virol., March 1, 1998; 72(3): 2253 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Planz, S. Ehl, E. Furrer, E. Horvath, M.-A. Brundler, H. Hengartner, and R. M. Zinkernagel A critical role for neutralizing-antibody-producing B cells, CD4+ T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers PNAS, June 24, 1997; 94(13): 6874 - 6879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ciurea, P. Klenerman, L. Hunziker, E. Horvath, B. M. Senn, A. F. Ochsenbein, H. Hengartner, and R. M. Zinkernagel Viral persistence in vivo through selection of neutralizing antibody-escape variants PNAS, March 14, 2000; 97(6): 2749 - 2754. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
